# Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication

> **NCT04100681** · NA · TERMINATED · sponsor: **Otivio AS** · enrollment: 16 (actual)

## Conditions studied

- Peripheral Vascular Disease
- Intermittent Claudication
- Walking, Difficulty
- Critical Limb Ischemia
- Ischemia Limb

## Interventions

- **DEVICE:** Active FlowOx™
- **DEVICE:** Sham FlowOx™ (Placebo)

## Key facts

- **NCT ID:** NCT04100681
- **Lead sponsor:** Otivio AS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-19
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-05-31
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** The study was terminated early due to slow recruitment and inability to recruit patients during the Covid-19 situation.
- **Last updated:** 2020-08-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04100681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04100681, "Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04100681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*